Amedeo Smart

Free Medical Literature Service

 

Amedeo

Breast Cancer
  Free Subscription

Articles published in
Cancer Res
    July 2026
  1. CLEAR KY, Arnone AA, Tsai YT, Wilson AS, et al
    Obesity and Age Elevate Tissue-Resident Microbiota Akkermansia muciniphila to Induce Oxidative Stress and Promote Breast Cancer Risk.
    Cancer Res. 2026 Jul 9. doi: 10.1158/0008-5472.CAN-25-2087.
    >> Share

  2. TARRAGO-CELADA J, Mahmood AS, Panina Y, Lalwani S, et al
    Targeting Cystine Addiction Suppresses Breast Cancer Lung Metastasis.
    Cancer Res. 2026 Jul 7. doi: 10.1158/0008-5472.CAN-25-3883.
    >> Share

  3. JURIC D, Islam KN, Gkotinakou IM, Zheng A, et al
    CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.
    Cancer Res. 2026 Jul 2. doi: 10.1158/0008-5472.CAN-25-1859.
    >> Share

    June 2026
  4. HOU X, Chen M, Guo X, Xie Y, et al
    The SDC1-ENO1 Axis in Cancer-Associated Fibroblasts Generates a Lactate-Rich Microenvironment That Drives Tumor Radioresistance.
    Cancer Res. 2026;86:3005-3025.
    >> Share

  5. MAIN SC, Elliott MJ, Singhawansa A, Zou J, et al
    Circulating Cell-Free DNA Methylation Profiling Enables Detection, Distinction, and Estrogen Receptor Status Classification of Advanced Breast Cancer.
    Cancer Res. 2026 Jun 10. doi: 10.1158/0008-5472.CAN-26-0076.
    >> Share

    May 2026
  6. YOO JY, Akter S, Zuo Q, Rilloraza M, et al
    In Silico Reconstruction of Primary and Metastatic Tumor Architecture Using Geographic Information System-Augmented Spatial Transcriptomics.
    Cancer Res. 2026;86:2555-2568.
    >> Share

  7. FLAHERTY RL, Hughes F, Sflomos G, Ronchi C, et al
    LOX Inhibition Disrupts a Collagen-Integrin-MYC Axis to Suppress Progression of Invasive Lobular Carcinoma.
    Cancer Res. 2026;86:2487-2507.
    >> Share

    April 2026
  8. YOUNG RG, Esquea EM, Ciraku L, Merzy J, et al
    ACSS2 Suppresses Ferroptosis to Drive Breast Cancer Brain Metastasis.
    Cancer Res. 2026 Apr 22. doi: 10.1158/0008-5472.CAN-25-3006.
    >> Share

  9. SHER EF, Fujihara KM, Tao A, Sastourne-Haletou P, et al
    Targeting DNA Polymerase Epsilon Induces Tumor Clearance and Activates an NF-kappaB-Mediated Inflammatory Response in Triple Negative Breast Cancer.
    Cancer Res. 2026 Apr 21. doi: 10.1158/0008-5472.CAN-25-2217.
    >> Share

  10. WONG H, Korsakova A, Wu AJ, Kularatnarajah L, et al
    An Analytical Framework Characterizes the Biological Processes that Shape Copy Number-Based Genome Instability Patterns in Breast Cancer.
    Cancer Res. 2026 Apr 9. doi: 10.1158/0008-5472.CAN-25-2569.
    >> Share

  11. TANKKA AT, Zhang Y, Einstein JM, Zhou CJ, et al
    Integrative CRISPR Screening and RNA Analyses Discover an Essential Role for PUF60 Interactions with 3' Splice Sites in Cancer Progression.
    Cancer Res. 2026;86:1586-1604.
    >> Share

    March 2026
  12. GAO A, Khatri PH, Ma G, Liu P, et al
    Integrated Multi-omic Profiling Identifies BRD8/EP400 as a Pivotal Chromatin Module Mediating Anti-HER2 Response in HR+/HER2+ Breast Cancer.
    Cancer Res. 2026 Mar 26. doi: 10.1158/0008-5472.CAN-25-4701.
    >> Share

  13. XING Y, Tan Y, Hu B, Zhang H, et al
    PAK5-Mediated Suppression of beta-Hydroxybutyrate Production Promotes Breast Cancer Metastasis and Can Be Overcome with Ketogenic Diet.
    Cancer Res. 2026;86:1435-1450.
    >> Share

    February 2026
  14. NANDI D, Parida S, Verma D, Foley JR, et al
    Spermine Oxidase Serves as a Key Functional Node in Microbial Dysbiosis-Induced Breast Carcinogenesis.
    Cancer Res. 2026 Feb 16:10.1158/0008-5472.CAN-25-2086.
    >> Share

  15. LUO Z, Li K, Yu Y, Liu Y, et al
    LDHB Deficiency in Fibroblasts Induces Lactate-Mediated Inflammatory Reprogramming that Promotes Breast Cancer Metastasis.
    Cancer Res. 2026 Feb 13. doi: 10.1158/0008-5472.CAN-25-2792.
    >> Share

  16. ORTEGA-ALVAREZ D, Tebar-Garcia D, Casado-Pelaez M, Olivares-Osuna D, et al
    Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic Strategies.
    Cancer Res. 2026 Feb 11. doi: 10.1158/0008-5472.CAN-24-2758.
    >> Share

  17. SINGHAL S, Li C, Aukerman A, Carriere M, et al
    Topology-Based Biomarkers Accurately Predict Breast Cancer Outcome and Survival.
    Cancer Res. 2026 Feb 9. doi: 10.1158/0008-5472.CAN-25-1216.
    >> Share

  18. BERENS EB, Khou S, Huang ET, Hoffman A, et al
    Neoplastic Immune Mimicry Potentiates Breast Tumor Progression.
    Cancer Res. 2026;86:587-603.
    >> Share

    January 2026
  19. CHEN S, Chang C, Liu X, Wang R, et al
    ACSL5 Mediates Adaptation to the Palmitic Acid-Enriched Pulmonary Microenvironment to Enhance Metastatic Breast Cancer Cell Survival and Lung Metastasis.
    Cancer Res. 2026 Jan 22. doi: 10.1158/0008-5472.CAN-25-0866.
    >> Share

  20. JIANG HL, Sun HF, Gao SP, Li LD, et al
    Retraction: SSBP1 Suppresses TGFbeta-Driven Epithelial-to-Mesenchymal Transition and Metastasis in Triple-Negative Breast Cancer by Regulating Mitochondrial Retrograde Signaling.
    Cancer Res. 2026;86:557.
    >> Share

  21. SOTTNIK JL, Shackleford MT, Nesiba CS, Richer AL, et al
    Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP Inhibition.
    Cancer Res. 2026 Jan 9. doi: 10.1158/0008-5472.CAN-25-1217.
    >> Share

  22. HERZOG SK, Stevens JH, Gu G, Grimm SL, et al
    Defective DNA Damage Response is a Targetable Therapeutic Vulnerability in ESR1 Mutant Breast Cancer.
    Cancer Res. 2026 Jan 7. doi: 10.1158/0008-5472.CAN-24-3891.
    >> Share

  23. PERURENA N, Watanabe M, Schade AE, Brown W, et al
    EZH2 Inhibitors Sensitize Breast Cancer to HER2 Kinase Inhibitors through Cooperative Effects on YAP and Pro-apoptotic Regulators.
    Cancer Res. 2026 Jan 5. doi: 10.1158/0008-5472.CAN-24-3113.
    >> Share

    December 2025
  24. RYSER MD, Greenwald MA, Monyak D, Sorribes IC, et al
    Spatially Discontinuous Mutation Topographies in Ductal Carcinoma In Situ Reveal Noncompetitive Growth Dynamics.
    Cancer Res. 2025;85:5084-5097.
    >> Share

  25. XIA Z, Liu W, Guo D, Chen L, et al
    circADAMTS12 Inhibits the Antitumor Activity of Microglia to Enable Metastatic Colonization in the Brain.
    Cancer Res. 2025;85:4977-4994.
    >> Share

  26. CHENG Y, Huang G, Liu X, Wu C, et al
    Fusion of Tumor Cells with Lipid-Associated Macrophages Drives Metastatic Progression of Breast Cancer.
    Cancer Res. 2025 Dec 4:OF1-OF18. doi: 10.1158/0008-5472.CAN-25-0261.
    >> Share

  27. ARNOUK SM, Kancheva D, Van Damme H, Courtoy GE, et al
    Depleting IL1R2+ Tumor-Infiltrating Regulatory T Cells with an ADCC-Prone Nanobody Construct Boosts the Efficacy of Anti-PD-1 Immunotherapy.
    Cancer Res. 2025;85:4681-4700.
    >> Share

    November 2025
  28. MOHAMMAD MIRZAEI N, Hur C, Terry MB, Dalerba P, et al
    Modeling Early-Onset Cancer Kinetics Reveals Changes in Underlying Risk and the Impact of Population Screening.
    Cancer Res. 2025;85:4558-4570.
    >> Share

  29. HOFER I, Kieffer Y, Mencattini A, Croizer H, et al
    An Extracellular Matrix-Producing Subset of Cancer-Associated Fibroblasts Drives Chemoresistance in Breast Cancer via SRC Activation and G0S2 Upregulation.
    Cancer Res. 2025 Nov 12. doi: 10.1158/0008-5472.CAN-25-0966.
    >> Share

  30. YIN S, Liu Y, Guan X, Wang X, et al
    Tetraspanin 13 Enhances Immune Evasion in Breast Cancer by Promoting MHC-I Degradation.
    Cancer Res. 2025 Nov 11. doi: 10.1158/0008-5472.CAN-25-1223.
    >> Share

  31. BONECHI F, Bacci M, Lorito N, Smiriglia A, et al
    ESR1 Activating Mutations Confer Metabolic Vulnerabilities in ER+ Breast Cancer.
    Cancer Res. 2025 Nov 7. doi: 10.1158/0008-5472.CAN-25-1339.
    >> Share

  32. BAUDRE L, Jouault G, Prompsy P, Saichi M, et al
    Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients.
    Cancer Res. 2025 Nov 6:OF1-OF16. doi: 10.1158/0008-5472.CAN-25-0995.
    >> Share

  33. BAUDRE L, Jouault G, Prompsy P, Saichi M, et al
    Characterization of Drug-Tolerant Persister Cells in Triple-Negative Breast Cancer Identifies a Shared Persistence Program across Treatments and Patients.
    Cancer Res. 2025 Nov 6. doi: 10.1158/0008-5472.CAN-25-0995.
    >> Share

    October 2025
  34. CHENOWETH AM, Cheung A, Chauhan J, Adams R, et al
    An Fc-Engineered Glycomodified Antibody Supports Proinflammatory Activation of Immune Effector Cells and Restricts Progression of Breast Cancer.
    Cancer Res. 2025 Oct 23:OF1-OF20. doi: 10.1158/0008-5472.CAN-24-3174.
    >> Share

  35. EL LAITHY Y, Abreu De Oliveira WA, Pabba A, Qualizza A, et al
    Chemotherapy-Treated Breast Cancer Cells Activate the WNT Signaling Pathway to Enter a Diapause-Like Early Persister State.
    Cancer Res. 2025 Oct 21. doi: 10.1158/0008-5472.CAN-24-4165.
    >> Share

    September 2025
  36. LIU J, Fang F, Yuan W, Chen T, et al
    Integrating Circulating Tumor DNA Dynamics and Sequential Organoid Drug Screening Enhances Breast Cancer Treatment Efficacy.
    Cancer Res. 2025 Sep 24. doi: 10.1158/0008-5472.CAN-25-0608.
    >> Share

  37. LIU P, Zheng J, Ma W, Lu J, et al
    Stress Promotes Lung Metastasis in Breast Cancer by Altering Neutrophil Differentiation.
    Cancer Res. 2025 Sep 24. doi: 10.1158/0008-5472.CAN-25-1763.
    >> Share

  38. KHAN F, Petrosyan E, Liu Y, Bahrami A, et al
    Microglial TBK1 Signaling Promotes Breast Cancer Brain Metastasis.
    Cancer Res. 2025 Sep 18. doi: 10.1158/0008-5472.CAN-25-1791.
    >> Share

  39. TAO JJ, Vasan N
    A New VISTA in Intracellular Checkpoint Signaling in Triple-Negative Breast Cancer.
    Cancer Res. 2025;85:3371-3372.
    >> Share

  40. ZHAO Y, Andoh T, Charles F, Reddy P, et al
    A Four Amino Acid Intracellular Motif of VISTA Blocks Growth Receptor Signaling in Cancer Cells to Induce Tumor Suppression.
    Cancer Res. 2025;85:3399-3415.
    >> Share

  41. MOLDRUP RIJ, Terp MG, Jakobsen ST, Ravnsborg T, et al
    SWI/SNF Functions as a Gatekeeper of Enhancer Chromatin Access to Control Progression of Mesenchymal Triple-Negative Breast Cancer.
    Cancer Res. 2025 Sep 10. doi: 10.1158/0008-5472.CAN-24-1660.
    >> Share

  42. AVELLINO A, Jiang X, Lee M, Yu J, et al
    An Olive Oil-Based High-Fat Diet Promotes Obesity-Driven Metastasis of Triple-Negative Breast Cancer.
    Cancer Res. 2025 Sep 5. doi: 10.1158/0008-5472.CAN-25-0822.
    >> Share

    August 2025
  43. ZHU XZ, Zhang HY, Zhou YF, Chen YY, et al
    Subtyping-Directed Precision Treatment Refines Traditional One-Size-Fits-All Therapy for HR+/HER2- Breast Cancer.
    Cancer Res. 2025 Aug 18. doi: 10.1158/0008-5472.CAN-24-5002.
    >> Share

  44. RINKENBAUGH AL, Qi Y, Cai S, Shao J, et al
    An Annotated Biobank of Triple-Negative Breast Cancer Patient-Derived Xenografts Features Treatment-Naive and Longitudinal Samples During Neoadjuvant Chemotherapy.
    Cancer Res. 2025 Aug 13. doi: 10.1158/0008-5472.CAN-24-5023.
    >> Share

  45. QI Z, He L, Xu Z, Luo X, et al
    PCBP2 Mediates Olaparib Resistance in Breast Cancer by Inhibiting m6A Methylation to Stabilize PARP1 mRNA.
    Cancer Res. 2025 Aug 7. doi: 10.1158/0008-5472.CAN-24-4751.
    >> Share

  46. GONG H, Li Y, Yang W, Xie Z, et al
    PRODH2-Mediated Metabolism in the Bone Microenvironment Promotes Breast Cancer Metastasis.
    Cancer Res. 2025 Aug 1. doi: 10.1158/0008-5472.CAN-24-4391.
    >> Share

    July 2025
  47. LAIGHT BJ, Harper D, Dmytryk N, Zhang CS, et al
    Fes-Deficient Macrophages Prime CD8+ T Cells to Stimulate Antitumor Immunity and Improve Immunotherapy Efficacy.
    Cancer Res. 2025;85:2643-2658.
    >> Share

    June 2025
  48. QIN X, Strand SH, Lee MR, Saraswathibhatla A, et al
    Single-Cell Expression Analysis of Ductal Carcinoma In Situ Identifies Complex Genotypic-Phenotypic Relationships Altering Epithelial Composition.
    Cancer Res. 2025;85:2302-2319.
    >> Share

  49. XIAO Y, Elmasry M, Bai JDK, Chen A, et al
    Eco-Evolutionary Guided Pathomic Analysis Detects Biomarkers to Predict Ductal Carcinoma In Situ Upstaging.
    Cancer Res. 2025;85:2537-2547.
    >> Share

    May 2025
  50. KIM EJ, Wang Y, Chen YL, Ma M, et al
    CARM1-mediated MAP2K4 methylation potentiates the oncogenic functions of MAP2K4 and constitutes a targetable dependency in triple-negative breast cancer.
    Cancer Res. 2025 May 29. doi: 10.1158/0008-5472.CAN-24-3476.
    >> Share

  51. ELKHOLI IE, Robert A, Malouf C, Wu JL, et al
    Targeting the Dependence on PIK3C3-mTORC1 Signaling in Dormancy-Prone Breast Cancer Cells Blunts Metastasis Initiation.
    Cancer Res. 2025 May 15:OF1-OF20. doi: 10.1158/0008-5472.CAN-23-2654.
    >> Share

  52. GOHARI Z, Stojanovic L, Rassool FV
    Combining STING Agonists with PARP Inhibitors Mounts an NK-Dependent Defense against Therapy-Resistant Breast Cancer.
    Cancer Res. 2025;85:1747-1749.
    >> Share

  53. ABBASI A, Steele CD, Bergstrom EN, Khandekar A, et al
    HRProfiler Detects Homologous Recombination Deficiency in Breast and Ovarian Cancers Using Whole-Genome and Whole-Exome Sequencing Data.
    Cancer Res. 2025 May 6. doi: 10.1158/0008-5472.CAN-24-2639.
    >> Share

    April 2025
  54. LUTZ C, Chao X, de Klein B, Bhin J, et al
    Large-Scale Characterization of Orthotopic Cell Line-Derived Xenografts Identifies TGF-beta Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness.
    Cancer Res. 2025 Apr 30. doi: 10.1158/0008-5472.CAN-24-2022.
    >> Share

  55. SOUTO EP, Gong P, Landua JD, Rajaram Srinivasan R, et al
    Lineage Tracing and Single-Cell RNA Sequencing Reveal a Common Transcriptional State in Breast Cancer Tumor-Initiating Cells Characterized by IFN/STAT1 Activity.
    Cancer Res. 2025;85:1390-1409.
    >> Share

  56. DOMMER AP, Kumarasamy V, Wang J, O'Connor TN, et al
    Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222.
    Cancer Res. 2025;85:1310-1326.
    >> Share

    March 2025
  57. PEDRETTI F, Abdalfttah M, Pellegrino B, Mateo F, et al
    Harnessing STING Signaling and Natural Killer Cells overcomes PARP Inhibitor Resistance in Homologous Recombination Deficient Breast Cancer.
    Cancer Res. 2025 Mar 11. doi: 10.1158/0008-5472.CAN-24-2531.
    >> Share

    February 2025
  58. SUN Z, Li Z, Wei Y, Xu L, et al
    SMARCA4 Inhibits Breast Cancer Progression and Metastasis through RHOA Suppression.
    Cancer Res. 2025 Feb 24. doi: 10.1158/0008-5472.CAN-24-2801.
    >> Share

  59. BADO IL
    Deterministic Role of FOXF2 in Organ-Specific Macrometastasis Transition.
    Cancer Res. 2025;85:639-641.
    >> Share

  60. ZHOU S, Zhang Y, Belmar J, Hou C, et al
    Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4/6 Inhibitors in Breast Cancer.
    Cancer Res. 2025 Feb 12. doi: 10.1158/0008-5472.CAN-24-2492.
    >> Share

  61. IPPOLITOV D, Lin YH, Spence J, Glogowska A, et al
    The Brain-Penetrant Pan ErbB Inhibitor Poziotinib Effectively Targets HER2+ Breast Cancer Brain Metastases.
    Cancer Res. 2025 Feb 11. doi: 10.1158/0008-5472.CAN-24-1793.
    >> Share

  62. METGE BJ, Williams L, Swain CA, Hinshaw DC, et al
    Ribosomal RNA Biosynthesis Functionally Programs Tumor-Associated Macrophages to Support Breast Cancer Progression.
    Cancer Res. 2025 Feb 4. doi: 10.1158/0008-5472.CAN-24-0707.
    >> Share

  63. MADORSKY ROWDO FP, Martini R, Ackermann SE, Tang CP, et al
    Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition.
    Cancer Res. 2025;85:551-566.
    >> Share

  64. TREMBATH HE, Spanheimer PM
    In Search of Representative Translational Cancer Model Systems.
    Cancer Res. 2025;85:407-409.
    >> Share

    January 2025
  65. TABET I, Orhan E, Candiello E, Fenou L, et al
    Replication-Poison Treatment in BRCA1-Deficient Breast Cancer Causes MRE11 Over-Resection that Induces Single-Stranded DNA Accumulation and Mitotic Catastrophe.
    Cancer Res. 2025 Jan 29. doi: 10.1158/0008-5472.CAN-24-1404.
    >> Share

  66. VAN ALSTEN SC, Love MI, Calhoun BC, Butler EN, et al
    Genomic Analysis Reveals Racial and Age-Related Differences in the Somatic Landscape of Breast Cancer and the Association with Socioeconomic Factors.
    Cancer Res. 2025 Jan 29. doi: 10.1158/0008-5472.CAN-24-1788.
    >> Share

  67. DEY P, Brisken C
    Breaking the Rhythm: Harnessing the Menstrual Cycle for Better Chemotherapy.
    Cancer Res. 2025 Jan 29. doi: 10.1158/0008-5472.CAN-25-0335.
    >> Share

  68. VISAL TH, Bayraktar R, den Hollander P, Attathikhun MA, et al
    Accumulation of CD38 in Hybrid Epithelial/Mesenchymal Cells Promotes Immune Remodeling and Metastasis in Breast Cancer.
    Cancer Res. 2025 Jan 24:OF1-OF18. doi: 10.1158/0008-5472.CAN-24-0400.
    >> Share

  69. PIERRO EW, Cottam MA, An H, Lehmann BD, et al
    Comparison of Lean, Obese, and Weight Loss Models Reveals TREM2 Deficiency Attenuates Breast Cancer Growth Uniquely in Lean Mice and Alters Clonal T Cell Populations.
    Cancer Res. 2025 Jan 22. doi: 10.1158/0008-5472.CAN-24-3511.
    >> Share

  70. GAO L, Huang J, Xia J, Zhao P, et al
    SNHG17 Reprograms Energy Metabolism of Breast Cancer by Activating Mitochondrial DNAs Transcription.
    Cancer Res. 2025 Jan 22. doi: 10.1158/0008-5472.CAN-24-1271.
    >> Share

  71. TAU S, Chamberlin MD, Yang H, Marotti JD, et al
    Oxidative Phosphorylation is a Metabolic Vulnerability of Endocrine Therapy-Tolerant Persister Cells in ER+ Breast Cancer.
    Cancer Res. 2025 Jan 9. doi: 10.1158/0008-5472.CAN-24-1204.
    >> Share

    December 2024
  72. CHEN SY, He PL, Lu LY, Lin MC, et al
    ST6GAL1-Mediated Sialylation of PECAM-1 Promotes a Transcellular Diapedesis-Like Process that Directs Lung Tropism of Metastatic Breast Cancer.
    Cancer Res. 2024 Dec 30. doi: 10.1158/0008-5472.CAN-24-1550.
    >> Share

  73. CHEN F, Ding K, Priedigkeit N, Elangovan A, et al
    Correction: Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells.
    Cancer Res. 2024;84:4298.
    >> Share

  74. FENG JR, Li X, Han C, Chang Y, et al
    C-Reactive Protein Induces Immunosuppression by Activating FcgammaR2B in Pulmonary Macrophages to Promote Lung Metastasis.
    Cancer Res. 2024;84:4184-4198.
    >> Share

  75. SHI W, Li L, Zhao H, Li Z, et al
    Targeting SHCBP1 Inhibits Tumor Progression by Restoring Ciliogenesis in Ductal Carcinoma.
    Cancer Res. 2024;84:4156-4172.
    >> Share

  76. BHAGWAT SV, Mur C, Vandekopple M, Zhao B, et al
    Imlunestrant is an Oral, Brain-Penetrant Selective Estrogen Receptor Degrader with Potent Antitumor Activity in ESR1 Wildtype and Mutant Breast Cancer.
    Cancer Res. 2024 Dec 9. doi: 10.1158/0008-5472.CAN-24-2608.
    >> Share

  77. FRIELING JS, Lynch CC
    Tales of Cancer-Induced Bone Disease from the Senescent Osteocyte Crypt.
    Cancer Res. 2024;84:3917-3918.
    >> Share

    November 2024
  78. JIANG WJ, Zhou TH, Huang HJ, Li LS, et al
    Breast Cancer Subtype-Specific Organotropism is Dictated by FOXF2-Regulated Metastatic Dormancy and Recovery.
    Cancer Res. 2024 Nov 26. doi: 10.1158/0008-5472.CAN-24-0479.
    >> Share

  79. ZENG W, Zhang R, Huang P, Chen M, et al
    Ferroptotic Neutrophils Induce Immunosuppression and Chemoresistance in Breast Cancer.
    Cancer Res. 2024 Nov 12. doi: 10.1158/0008-5472.CAN-24-1941.
    >> Share

  80. SHEA A, Eyal-Lubling Y, Guerrero-Romero D, Manzano Garcia R, et al
    Modeling Drug Responses and Evolutionary Dynamics using Patient-Derived Xenografts Reveals Precision Medicine Strategies for Triple Negative Breast Cancer.
    Cancer Res. 2024 Nov 8. doi: 10.1158/0008-5472.CAN-24-1703.
    >> Share

    October 2024
  81. KUETT L, Bollhagen A, Tietscher S, Sobottka B, et al
    Distant Metastases of Breast Cancer Resemble Primary Tumors in Cancer Cell Composition but Differ in Immune Cell Phenotypes.
    Cancer Res. 2024 Oct 22. doi: 10.1158/0008-5472.CAN-24-1211.
    >> Share

  82. CACKOWSKI FC, Korkaya H
    Breast Cancer Disseminated Tumor Cells: Do They Stay and Fight or Run and Hide?
    Cancer Res. 2024;84:3319-3321.
    >> Share

  83. PAREJA F, Dopeso H, Wang YK, Gazzo AM, et al
    A Genomics-Driven Artificial Intelligence-Based Model Classifies Breast Invasive Lobular Carcinoma and Discovers CDH1 Inactivating Mechanisms.
    Cancer Res. 2024;84:3478-3489.
    >> Share

  84. FALCONE M, Salhia B, Hughes Halbert C, Roussos Torres ET, et al
    Impact of Structural Racism and Social Determinants of Health on Disparities in Breast Cancer Mortality.
    Cancer Res. 2024 Oct 2. doi: 10.1158/0008-5472.CAN-24-1359.
    >> Share

  85. GEMMA C, Lai CF, Singh AK, Belfiore A, et al
    Induction of the TEAD Co-activator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer.
    Cancer Res. 2024 Oct 2. doi: 10.1158/0008-5472.CAN-24-0013.
    >> Share

  86. PURDY SC, Ford HL
    Remembering Hypoxia: Uncovering the Long-Term Effects of Transient Oxygen Deprivation on IFN Signaling and Progression of Breast Cancer.
    Cancer Res. 2024;84:3125-3127.
    >> Share

  87. GONZALEZ ME, Brophy B, Eido A, Leonetti AE, et al
    CCN6 Suppresses Metaplastic Breast Carcinoma by Antagonizing Wnt/beta-Catenin Signaling to Inhibit EZH2-Driven EMT.
    Cancer Res. 2024;84:3235-3249.
    >> Share

  88. SHIN SY, Chew NJ, Ghomlaghi M, Chueh AC, et al
    Integrative Modeling of Signaling Network Dynamics Identifies Cell Type-Selective Therapeutic Strategies for FGFR4-Driven Cancers.
    Cancer Res. 2024;84:3296-3309.
    >> Share

    September 2024
  89. KAUR J, Adhikari M, Sabol HM, Anloague A, et al
    Single-cell Transcriptomic Analysis Identifies Senescent Osteocytes that Trigger Bone Destruction in Breast Cancer Metastasis.
    Cancer Res. 2024 Sep 23. doi: 10.1158/0008-5472.CAN-24-0857.
    >> Share

  90. LUO M, Shen N, Shang L, Fang Z, et al
    Simultaneous Targeting of NQO1 and SOD1 Eradicates Breast Cancer Stem Cells via Mitochondrial Futile Redox Cycling.
    Cancer Res. 2024 Sep 12. doi: 10.1158/0008-5472.CAN-24-0800.
    >> Share

  91. GILKES DM, Chaturvedi P, Bajpai S, Wong CC, et al
    Retraction: Collagen Prolyl Hydroxylases Are Essential for Breast Cancer Metastasis.
    Cancer Res. 2024;84:2927.
    >> Share

  92. SAMANTA D, Park Y, Andrabi SA, Shelton LM, et al
    Retraction: PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis.
    Cancer Res. 2024;84:2926.
    >> Share

  93. CONNER SJ, Borges HB, Guarin JR, Gerton TJ, et al
    Obesity Induces Temporally Regulated Alterations in the Extracellular Matrix That Drive Breast Tumor Invasion and Metastasis.
    Cancer Res. 2024;84:2761-2775.
    >> Share

    August 2024
  94. ZHOU Z, Si Y, Zhang J, Chen K, et al
    A Dual-Payload Antibody-Drug Conjugate Targeting CD276/B7-H3 Elicits Cytotoxicity and Immune Activation in Triple-Negative Breast Cancer.
    Cancer Res. 2024 Aug 26. doi: 10.1158/0008-5472.CAN-23-4099.
    >> Share

  95. LI YW, Dai LJ, Wu XR, Zhao S, et al
    Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies.
    Cancer Res. 2024 Aug 26. doi: 10.1158/0008-5472.CAN-23-4066.
    >> Share

  96. LEWIS MW, King CM, Wisniewska K, Regner MJ, et al
    CRISPR Screening of Transcribed Super-Enhancers Identifies Drivers of Triple-Negative Breast Cancer Progression.
    Cancer Res. 2024 Aug 26. doi: 10.1158/0008-5472.CAN-23-3995.
    >> Share

  97. LI M, Lulla AR, Wang Y, Tsavachidis S, et al
    Low Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer.
    Cancer Res. 2024 Aug 26. doi: 10.1158/0008-5472.CAN-23-4130.
    >> Share

  98. HEATH J, Mirabelli C, Annis MG, Sabourin V, et al
    The Neurodevelopmental Protein POGZ Suppresses Metastasis in Triple Negative Breast Cancer by Attenuating TGFbeta Signaling.
    Cancer Res. 2024 Aug 13. doi: 10.1158/0008-5472.CAN-23-3887.
    >> Share

  99. BUSHNELL GG, Sharma D, Wilmot HC, Zheng M, et al
    Natural Killer Cell Regulation of Breast Cancer Stem Cells Mediates Metastatic Dormancy.
    Cancer Res. 2024 Aug 6. doi: 10.1158/0008-5472.CAN-24-0030.
    >> Share

    July 2024
  100. WANG X, Qu Y, Xu Q, Jiang Z, et al
    NQO1 Triggers Neutrophil Recruitment and NET formation to Drive Lung Metastasis of Invasive Breast Cancer.
    Cancer Res. 2024 Jul 29. doi: 10.1158/0008-5472.CAN-24-0291.
    >> Share

  101. HSU WJ, Chiang MC, Chao YC, Chang YC, et al
    Arginine methylation of DDX3 by PRMT1 mediates mitochondrial homeostasis to promote breast cancer metastasis.
    Cancer Res. 2024 Jul 23. doi: 10.1158/0008-5472.CAN-23-3829.
    >> Share

  102. PIEMONTE KM, Ingles NN, Weber Bonk KL, Valentine MJ, et al
    Targeting YES1 Disrupts Mitotic Fidelity and Potentiates the Response to Taxanes in Triple-Negative Breast Cancer.
    Cancer Res. 2024 Jul 22. doi: 10.1158/0008-5472.CAN-23-2558.
    >> Share

  103. HUANG YZ, Sang MY, Xi PW, Xu RX, et al
    FANCI Inhibition Induces PARP1 Redistribution to Enhance the Efficacy of PARP Inhibitors in Breast Cancer.
    Cancer Res. 2024 Jul 22. doi: 10.1158/0008-5472.CAN-23-2738.
    >> Share

  104. HILLIS AL, Martin TD, Manchester HE, Hogstrom J, et al
    Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer.
    Cancer Res. 2024 Jul 18. doi: 10.1158/0008-5472.CAN-24-0970.
    >> Share

  105. IRIONDO O, Mecenas D, Li Y, Chin CR, et al
    Hypoxic Memory Mediates Prolonged Tumor Intrinsic Type I Interferon Suppression to Promote Breast Cancer Progression.
    Cancer Res. 2024 Jul 11. doi: 10.1158/0008-5472.CAN-23-2028.
    >> Share

  106. LEE G, Wong C, Cho A, West JJ, et al
    E-cadherin Induces Serine Synthesis to Support Progression and Metastasis of Breast Cancer.
    Cancer Res. 2024 Jul 3. doi: 10.1158/0008-5472.CAN-23-3082.
    >> Share

    June 2024
  107. MENEGOLLO M, Bentham RB, Henriques T, Ng SQ, et al
    Multi-State Gene Cluster Switches Determine the Adaptive Mitochondrial And Metabolic Landscape of Breast Cancer.
    Cancer Res. 2024 Jun 26. doi: 10.1158/0008-5472.CAN-23-3172.
    >> Share

  108. XU G, Huang R, Wumaier R, Lyu J, et al
    Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer.
    Cancer Res. 2024 Jun 20. doi: 10.1158/0008-5472.CAN-23-3998.
    >> Share

  109. TUCKER JB, Carlsen CL, Scribano CM, Pattaswamy SM, et al
    CENP-E inhibition induces chromosomal instability and synergizes with diverse microtubule-targeting agents in breast cancer.
    Cancer Res. 2024 Jun 4. doi: 10.1158/0008-5472.CAN-23-3332.
    >> Share

  110. SUN X, Verma SP, Jia G, Wang X, et al
    Case-Case Genome-Wide Analyses Identify Subtype-Informative Variants that Confer Risk for Breast Cancer.
    Cancer Res. 2024 Jun 4. doi: 10.1158/0008-5472.CAN-23-3854.
    >> Share

  111. ELEMENTO O
    How Artificial Intelligence Unravels the Complex Web of Cancer Drug Response.
    Cancer Res. 2024;84:1745-1746.
    >> Share

    May 2024
  112. HUANG MY, Hu SY, Dong J, Deng L, et al
    The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer.
    Cancer Res. 2024 May 15. doi: 10.1158/0008-5472.CAN-23-2781.
    >> Share

    April 2024
  113. XIA J, Zhang L, Peng X, Tu J, et al
    IL1R2 blockade alleviates immunosuppression and potentiates anti-PD-1 efficacy in triple-negative breast cancer.
    Cancer Res. 2024 Apr 24. doi: 10.1158/0008-5472.CAN-23-3429.
    >> Share

  114. ZHENG SM, Feng YC, Zhu Q, Li RQ, et al
    MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer.
    Cancer Res. 2024 Apr 9:OF1-OF15. doi: 10.1158/0008-5472.CAN-23-3046.
    >> Share

    March 2024
  115. ZHANG M, Zhou K, Wang Z, Liu T, et al
    A subpopulation of luminal progenitors secretes pleiotrophin to promote angiogenesis and metastasis in inflammatory breast cancer.
    Cancer Res. 2024 Mar 20. doi: 10.1158/0008-5472.CAN-23-2640.
    >> Share

  116. QIU Y, Wang X, Sun Y, Jin T, et al
    ACSL4-mediated membrane phospholipid remodeling induces integrin beta1 activation to facilitate triple-negative breast cancer metastasis.
    Cancer Res. 2024 Mar 12. doi: 10.1158/0008-5472.CAN-23-2491.
    >> Share

    October 2023
  117. YU S, Wang Y, Gong X, Fan Z, et al
    LncRNA AGPG Confers Endocrine Resistance in Breast Cancer by Promoting E2F1 Activity.
    Cancer Res. 2023;83:3220-3236.
    >> Share

    August 2023
  118. AMAYA RAMIREZ CC, Loayza-Puch F
    Breast Cancer Metastatic Progression Requires mRNA Posttranscriptional Suppression.
    Cancer Res. 2023;83:2448-2449.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016